JUL 25, 2017 02:40 PM PDT

Growing A Better Flu Vaccine in Chicken Eggs

WRITTEN BY: Kara Marker

Scientists use chicken eggs to grow flu viruses for use in vaccines. However, the flu vaccine is infamous for having questionable effectiveness. Now, scientists know that it’s partially because the flu virus is mutating inside of the chicken eggs. The solution? Stop the mutation.

Cells of the upper respiratory tract are where influenza virus infection occurs. Red marks basal cells, green marks ciliated cells, and blue marks cell nuclei. Credit: Rebekah Dumm, Duke University

How effective is the current flu vaccine really? It’s hard to say, but it was estimated to be 42 percent effective during the 2015-2016 flu season. This is due in part to errors in strain selection, which has to occur months in advance, and the flu virus is infamous for continuously evolving. In the present case, the problem is that even when the correct strain is predicted, that strain changes during growth in chicken eggs.

From Duke University, scientists have devised a way to prevent human flu viruses from changing while they are grown in chicken eggs. By doing so, they’ve created a way to produce the seasonal flu vaccine faster, better, and cheaper. Not to mention, they can create a more effective vaccine.

"We have solved a fundamental problem that scientists had accepted would be part of vaccine production - that the virus is always going to mutate if it is grown in eggs," explained senior study author Nicholas S. Heaton, PhD.

How specifically does the virus change as it grows in a chicken egg as opposed to, say, the human nose? To infect cells in the chicken egg instead of in human cells, the virus has to alter a protein called hemagglutinin (HA). During production, HA is incorporated into flu vaccines as a method of activating the immune response. But if the HA in the chicken egg virus is different than the HA in the flu virus that ends up infected people, then the vaccine won’t be effective.

"Because viruses typically mutate during vaccine production, manufacturers have to screen for mutations, and decide which ones can be tolerated and which ones can't," Heaton explained. "If we can eliminate mutations, we can cut back dramatically on production time."

Heaton’s approach is relatively simple. He and his research team created a flu virus expressing both egg HA and human HA, creating a “bivalent” virus as opposed to a “monovalent” virus. They vaccinated mice with both bivalent and monovalent vaccines and saw equal immune responses, so they knew the new bivalent vaccine was just as effective as the regular vaccine.

"We reasoned that the egg-adapted HA would do all the heavy lifting," Heaton explained. "It could do the virus entry work and just bring the other (human) one along for the ride. In effect, that would alleviate the strong selective pressure on the human HA to mutate."

Next they looked at the potential of the bivalent approach to work with even the most troublesome viruses to grow in the lab, and they found success.

"There's a laundry list of problems with the flu vaccine, but this is something that we can solve now, not 10 or 15 years down the line," Heaton said.

The present study was published in the journal mBio.

 

Source: Duke University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 25, 2018
Immunology
SEP 25, 2018
A Better Place to Gain Weight
Weight gain among genders can have different outcomes....
SEP 26, 2018
Immunology
SEP 26, 2018
What Superbug? A New Antibiotic Contender
Scientists from a biotechnology corporation, Genentech, have altered a protein that blocks a signaling pathway in gram-negative bacteria to engineer a new antibiotic, currently called G0775,...
OCT 08, 2018
Immunology
OCT 08, 2018
Nuclear Imaging: The Next Generation of Biopsy
A team of researchers has published their work in the Journal of Nuclear Medicine describing techniques with PET imaging as an alternative to biopsy methods....
OCT 22, 2018
Immunology
OCT 22, 2018
Barcoding for Cancer Immunity Genes
Scientists develop a novel technology that allows for protein barcoding to reveal gene function...
NOV 12, 2018
Neuroscience
NOV 12, 2018
Role Of Choroid Plexus Protein Klotho In Aging
Inflammaging, describes the increase in an inflammatory alteration in the brain, due to aging and predicts the morbidity and mortality in older humans....
DEC 18, 2018
Immunology
DEC 18, 2018
Enhancing Antibody Validation and Reproducibility
Many immunological technologies are only as good as the antibody being used for antigen detection. As such, there is enormous value with providing the scie...
Loading Comments...